REGN
Regeneron Pharmaceuticals, Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $16.9B | +11.0% |
| Gross profit | $6.2B2019 | +18.0% |
| Operating income | $4.9B | 0.0% |
| Net income | $4.8B | +5.1% |
| EPS | $45.29 | +6.3% |
| Free cash flow | $3.8B | +15.3% |